Tovorafenib (DAY101) Monotherapy for Patients With Melanoma and Other Solid Tumors
Day One Biopharmaceuticals, Inc.
Day One Biopharmaceuticals, Inc.
Bayer
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)